Skip to content

Prospective Double-blinded Randomized Controlled Clinical Trial evaluating efficacy of local infiltrative analgesia in patients undergoing lumbar decompression surgeries

Prospective Double-blinded Randomized Controlled Clinical Trial evaluating efficacy of local infiltrative analgesia in patients undergoing lumbar decompression surgeries

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0004222
Enrollment
80
Registered
2019-08-20
Start date
2018-09-03
Completion date
Unknown
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : The study subjects will be randomized into two groups- injection group and control group. Subjects will be randomly assigned to either group using online randomizer software. The s

Sponsors

Seoul Gangnam Wooridul Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 19-75 years 2. Patients with isolated diagnosis of symptomatic one/two-level lumbar central stenosis or disc herniations. 3. Planned for elective one/two-level uni/bi-lateral open lumbar laminectomy with or without discectomy 4. No known allergies to constituents of medication to be instituted as part of study

Exclusion criteria

Exclusion criteria: 1. Previous lumbar surgeries 2. On medications for other medical issues 3. Multi-level symptomatic spinal conditions 4. Peripheral neuropathy 5. h/o psychiatric disorders and neuromuscular disorders 6. Workmen compensation claim candidates 7. Patients with systemic inflammatory disorders e,g rheumatoid arthritis 8. Patients on steroids/immunosuppressant medications

Design outcomes

Primary

MeasureTime frame
VAS-B scores;Total analgesia consumption;complications;adverse effects of medications;ODI scores

Secondary

MeasureTime frame
Any unexpected outcome/complication

Countries

Korea, Republic of

Contacts

Public ContactEun Soo

Seoul Gangnam Wooridul Hospital

erupt0123@naver.com+82-2-513-8147

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026